Novartis Tops Q1 EPS by 2c
- ByInvesting.com-
Novartis (NYSE:NVS) reported Q1 EPS of $1.46, $0.02 better than the analyst estimate of $1.44. Revenue for the quarter came in at $12.53 billion versus the consensus estimate of...
Novartis (NYSE:NVS) reported Q1 EPS of $1.46, $0.02 better than the analyst estimate of $1.44. Revenue for the quarter came in at $12.53 billion versus the consensus estimate of...
Investing.com - Novartis ADR reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Novartis ADR announced earnings...
By Peter NurseInvesting.com -- Stocks in focus in premarket trade on Monday, April 4th. Please refresh for updates.Twitter (NYSE:TWTR) stock soared 20% after a regulatory filing...
Concerns over high inflation levels and the war in Ukraine have meant increased volatility for stocks on Wall Street and other exchanges around the world. For instance, the DAX...
Interest rates in the US are going up. The country's red-hot inflation level has prompted the Federal Reserve to step in to achieve its dual mandate of "price stability and maximum...
Executive SummaryShareholder meetings and conferences ramp up after a busy summer and ahead of the next earnings seasonThe Delta variant forced many companies to quickly switch...
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | |||||
| Technical Indicators | |||||
| Summary |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 38.51 | 38.86 | 38.01 | +0.02 | +0.05% | 567.75K | NYSE | |||
| 52.75 | 52.96 | 51.58 | +1.11 | +2.15% | 21.25M | NYSE | |||
| 26.52 | 26.88 | 26.31 | +0.17 | +0.65% | 4.24M | NYSE | |||
| 82.20 | 82.79 | 80.77 | +0.03 | +0.04% | 829.02K | NASDAQ | |||
| 65.39 | 65.84 | 64.41 | +0.37 | +0.57% | 1.42M | NYSE | |||
| 165.99 | 169.26 | 165.94 | -6.59 | -3.82% | 2.08M | NYSE | |||
| 25.17 | 25.50 | 24.92 | -0.44 | -1.72% | 19.82K | NASDAQ | |||
| 119.12 | 120.00 | 115.51 | -1.01 | -0.84% | 19.76M | NYSE | |||
| 23.99 | 23.99 | 23.98 | -0.81 | -3.27% | 18.00 | NYSE | |||
| 159.56 | 161.01 | 150.40 | +4.02 | +2.58% | 4.92M | NASDAQ | |||
| 33.20 | 33.58 | 32.42 | +0.67 | +2.06% | 865.37K | NYSE | |||
| 4.69 | 4.72 | 4.53 | -0.030 | -0.64% | 68.67K | NASDAQ | |||
| 258.23 | 260.58 | 256.70 | +2.29 | +0.89% | 1.17M | NYSE | |||
| 0.177 | 0.1858 | 0.1704 | -0.0164 | -8.48% | 13.71M | NASDAQ | |||
| 15.97 | 17.37 | 15.60 | -1.79 | -10.08% | 11.55M | NYSE |